Release Date: 20/05/13 16:46 Summary: Company Insight - MD Gives Company-wide Update Price Sensitive: No Download Document 339.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%